Skip to main navigation Skip to search Skip to main content

Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial

  • Nancy U. Lin
  • , Virginia Borges
  • , Carey Anders
  • , Rashmi K. Murthy
  • , Elisavet Paplomata
  • , Erika Hamilton
  • , Sara Hurvitz
  • , Sherene Loi
  • , Alicia Okines
  • , Vandana Abramson
  • , Philippe L. Bedard
  • , Mafalda Oliveira
  • , Volkmar Mueller
  • , Amelia Zelnak
  • , Michael P. DiGiovanna
  • , Thomas Bachelot
  • , A. Jo Chien
  • , Ruth O’Regan
  • , Andrew Wardley
  • , Alison Conlin
    • David Cameron, Lisa Carey, Giuseppe Curigliano, Karen Gelmon, Sibylle Loibl, Jo Al Mayor, Suzanne McGoldrick, Xuebei An, Eric P. Winer

Research output: Contribution to journal › Article › peer-review

498 Scopus citations

Fingerprint

Dive into the research topics of 'Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology